180 related articles for article (PubMed ID: 20205677)
1. Anabolics in osteoporosis: the emerging therapeutic tool.
Trivedi R; Mithal A; Chattopadhyay N
Curr Mol Med; 2010 Feb; 10(1):14-28. PubMed ID: 20205677
[TBL] [Abstract][Full Text] [Related]
2. Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?
Girotra M; Rubin MR; Bilezikian JP
Treat Endocrinol; 2006; 5(6):347-58. PubMed ID: 17107220
[TBL] [Abstract][Full Text] [Related]
3. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
4. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
5. Anabolic skeletal therapy for osteoporosis.
Girotra M; Rubin MR; Bilezikian JP
Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
[TBL] [Abstract][Full Text] [Related]
6. Investigational anabolic therapies for osteoporosis.
Trivedi R; Goswami R; Chattopadhyay N
Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
[TBL] [Abstract][Full Text] [Related]
7. Miscellaneous and experimental agents.
Reginster JY
Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
[TBL] [Abstract][Full Text] [Related]
8. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
9. Emerging anabolic treatments in osteoporosis.
Mosekilde L; Tørring O; Rejnmark L
Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
[TBL] [Abstract][Full Text] [Related]
10. Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
Bilezikian JP; Rubin MR
Curr Osteoporos Rep; 2006 Mar; 4(1):5-13. PubMed ID: 16527002
[TBL] [Abstract][Full Text] [Related]
11. [Anabolic therapy of osteoporosis].
Fernández-García D; Alonso G; Muñoz-Torres M
Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone as an anabolic skeletal therapy.
Rubin MR; Bilezikian JP
Drugs; 2005; 65(17):2481-98. PubMed ID: 16296873
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
14. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives.
Baron R; Hesse E
J Clin Endocrinol Metab; 2012 Feb; 97(2):311-25. PubMed ID: 22238383
[TBL] [Abstract][Full Text] [Related]
15. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
[TBL] [Abstract][Full Text] [Related]
16. Potential new drug targets for osteoporosis.
Deal C
Nat Clin Pract Rheumatol; 2009 Jan; 5(1):20-7. PubMed ID: 19098925
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
[TBL] [Abstract][Full Text] [Related]
18. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
19. Anabolic Therapy for the Treatment of Osteoporosis in Childhood.
Ward LM; Rauch F
Curr Osteoporos Rep; 2018 Jun; 16(3):269-276. PubMed ID: 29589203
[TBL] [Abstract][Full Text] [Related]
20. Drug combination strategies for osteoporosis.
Audran M
Joint Bone Spine; 2006 Jul; 73(4):374-8. PubMed ID: 16765628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
